Medical News: EULAR: RA Antibodies Key to Abatacept Response - in Rheumatology, EULAR from MedPage Today
Links shared publicly online about this topic.
- 51total visits
Medical News: EULAR: RA Antibodies Key to Abatacept Response - in Rheumatology, EULAR from MedPage Today
View full resource at medpagetoday.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Healthy Living, Orencia, Rheumatology, News, Medical
Most Recently Shared on August 23, 2011 at 6:59 pm By:
Medical News: EULAR: RA Antibodies Key to Abatacept Response - in Rheumatology, EULAR from MedPage Today http://t.co/PtRtjb8 #health
Medical News: EULAR: RA Antibodies Key to Abatacept Response - in Rheumatology, EULAR from MedPage Today
medpagetoday.com — “LONDON -- Rheumatoid arthritis patients who were seropositive -- particularly for anti-cyclic citrullinated peptide (CCP) antibodies -- responded better to treatment with abatacept (Orencia) than pati” View full resource at medpagetoday.com
Most Recently Shared on May 29, 2011 at 4:20 am By:
EULAR: RA Antibodies Key to Abatacept Response (CME/CE): LONDON (MedPage Today) -- Rheumatoid arthritis patients... http://bit.ly/kP4e2l
Medical News: EULAR: RA Antibodies Key to Abatacept Response - in Rheumatology, EULAR from MedPage Today
medpagetoday.com — “LONDON -- Rheumatoid arthritis patients who were seropositive -- particularly for anti-cyclic citrullinated peptide (CCP) antibodies -- responded better to treatment with abatacept (Orencia) than pati” View full resource at medpagetoday.com
Most Recently Shared on May 28, 2011 at 7:24 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday EULAR: RA Antibodies Key to Abatacept Response (CME/CE) http://bit.ly/kU2y5w #medical #Health
Advertisement
